Key Class Action Lawsuit Deadlines
In a crucial update for investors, Holzer & Holzer, LLC emphasizes the upcoming deadlines to help potential lead plaintiffs in key shareholder class action lawsuits. This guidance is vital for anyone who has invested in MoonLake Immunotherapeutics, DexCom, or Synopsys.
MoonLake Immunotherapeutics (MLTX)
About the Lawsuit
The class action against MoonLake Immunotherapeutics (NASDAQ: MLTX) revolves around allegations of misleading statements and undisclosed material facts related to the product SLK's supposed advantages over monoclonal antibodies. This case covers a significant time frame, where if you purchased shares from March 10, 2024, to September 29, 2025, and faced losses, you may be eligible to seek redress.
Contact Information
If you believe you have a case, it's important to reach out. For legal guidance, contact Corey D. Holzer, Esq. at cholzer@holzerlaw.com or call (888) 508-6832 for assistance. More details can also be found on the firm’s website.
Deadline
The deadline to request the appointment as the lead plaintiff in this case is set for December 15, 2025. Missing this date may forfeit your opportunity.
DexCom, Inc. (DXCM)
Overview of the Case
In the case against DexCom, Inc. (NASDAQ: DXCM), allegations claim that the company made false or misleading statements regarding significant design changes to its G6 and G7 devices. If you purchased shares between January 8, 2024, and September 17, 2025, and incurred losses, it’s advisable to determine your legal options.
How to Act
Interested investors are encouraged to seek legal counsel with any concerns. Corey D. Holzer, Esq. is available at cholzer@holzerlaw.com, or by phone at (888) 508-6832 for direct assistance. Further information can be accessed on their official website.
Important Dates
Be cautious about the approaching deadline; requests to be named as lead plaintiff must be submitted by December 26, 2025.
Synopsys, Inc. (SNPS)
Details on the Litigation
Regarding Synopsys, Inc. (NASDAQ: SNPS), the class action lawsuit claims that false representations and omitted key economic information concerning Synopsys’s Design IP business were made. If your investments between December 4, 2024, and September 9, 2025, resulted in significant losses, exploring your legal recourse is beneficial.
Reach Out for Support
To discuss your rights and find out more, contact Corey D. Holzer, Esq. via email at cholzer@holzerlaw.com or through their dedicated phone line at (888) 508-6832. You can also visit the firm’s official website.
Deadline for Claims
Don’t overlook the crucial deadline; the last day to apply for lead plaintiff status is December 30, 2025. It’s essential to act before this date to protect your interests.
About Holzer & Holzer, LLC
Holzer & Holzer, LLC stands as a top-rated securities litigation firm, recognized for its unwavering dedication to representing investors and shareholders in legal disputes nationwide. Since its inception in 2000, the firm has worked tirelessly to recover substantial amounts for investors affected by corporate wrongdoing.
Frequently Asked Questions
What is the role of a lead plaintiff?
The lead plaintiff represents the interests of all class members in a class action lawsuit, ensuring those interests are effectively advocated in court.
How can I determine if I'm eligible?
If you held shares during the specified time frames and experienced financial losses, contacting a lawyer can help clarify your potential eligibility.
What should I do if I missed the deadline?
If you missed a deadline, consult with legal counsel immediately to see if you have other options or remedies available.
Where can I get updates on the lawsuits?
Investors should regularly consult the official website of Holzer & Holzer, LLC for the latest updates and information regarding ongoing cases.
Who can I contact for more information?
Investors are encouraged to contact Corey D. Holzer at (888) 508-6832 or via email to obtain further assistance regarding their specific situations or inquiries.